Opportunity ID: 252853

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-DK-14-502
Funding Opportunity Title: Limited Competition: Continuation of the Type 2 Diabetes in Adolescents and Youth (TODAY) Study (U01)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Food and Nutrition
Health
Category Explanation:
Expected Number of Awards: 1
Assistance Listings: 93.847 — Diabetes, Digestive, and Kidney Diseases Extramural Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Mar 21, 2014
Last Updated Date:
Original Closing Date for Applications: Jun 19, 2014
Current Closing Date for Applications: Jun 19, 2014
Archive Date: Jul 20, 2014
Estimated Total Program Funding: $10,000,000
Award Ceiling: $10,000,000
Award Floor:

Eligibility

Eligible Applicants: Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following:
Non-domestic (non-U.S.) Entities (Foreign Organizations); This FOA is a limited competition for continuation of the TODAY study, which was previously reviewed in response to RFA-DK-08-502. Only the currently funded DCC is eligible to apply. Only the currently funded CCs are eligible to be CCs as subcontracts to the DCC.

Additional Information

Agency Name: National Institutes of Health
Description: The purpose of this Funding Opportunity Announcement (FOA) is to continue follow-up of the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) cohort through a cooperative agreement. TODAY was a multi-center controlled clinical trial examining the efficacy of three approaches to treat recently diagnosed type 2 diabetes in youth ages 10-17 years. TODAY demonstrated that combination therapy with metformin plus rosiglitazone sustained glycemic control longer than either metformin plus an intensive lifestyle program or metformin alone.TODAY study results also suggest that type 2 diabetes is more aggressive when it occurs at a young age. The primary purpose of this FOA is to continue follow-up of the TODAY cohort to define the long-term clinical course of youth-onset type 2 diabetes.
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-14-502.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email: FBOWebmaster@OD.NIH.GOV

Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
93.847 FORM-C FORMS-C PKG00194239 May 19, 2014 Jun 19, 2014 View

Package 1

Mandatory forms

252853 RR_SF424_2_0-2.0.pdf

252853 PHS398_ResearchPlan_2_0-2.0.pdf

252853 PHS398_CoverPageSupplement_2_0-2.0.pdf

252853 RR_KeyPersonExpanded_2_0-2.0.pdf

252853 RR_OtherProjectInfo_1_3-1.3.pdf

252853 PerformanceSite_2_0-2.0.pdf

Optional forms

252853 RR_SubawardBudget30_1_3-1.3.pdf

252853 PlannedReport-1.0.pdf

252853 PHS398_CumulativeInclusionReport-1.0.pdf

252853 PHS398_ModularBudget_1_2-1.2.pdf

252853 RR_Budget_1_3-1.3.pdf

2025-07-09T10:10:47-05:00

Share This Post, Choose Your Platform!

About the Author: